(Total Views: 513)
Posted On: 04/07/2020 10:35:56 PM
Post# of 145249
henry...just to make sure I understand...so if a patient has HIV and a low CD4 count, it will not be improved by leronlimab as it was described today for covid? I was assuming that there are other MOAs for these indications but that CD4 restoration would be common amongst all indications. Appreciate your expertise as this is not my background and I may be thinking too simplistic. TIA
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)